Citation Impact
Citing Papers
2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease
2010 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary
2014 Standout
Nanomaterials for medical diagnosis and therapy
2007
Artificially engineered magnetic nanoparticles for ultra-sensitive molecular imaging
2006 Standout
ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction
2007
Detection of Vascular Expression of E-selectin in Vivo with MR Imaging
2006
Recommendations for Noninvasive Evaluation of Native Valvular Regurgitation
2017 Standout
Universal Definition of Myocardial Infarction
2007 Standout
Molecular imaging in living subjects: seeing fundamental biological processes in a new light
2003 Standout
Phase I Clinical Evaluation of Citrate-coated Monocrystalline Very Small Superparamagnetic Iron Oxide Particles as a New Contrast Medium for Magnetic Resonance Imaging
2004
Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications
2004 Standout
In women with symptoms of cardiac ischemia, nonobstructive coronary arteries, and microvascular dysfunction, angiotensin-converting enzyme inhibition is associated with improved microvascular function: A double-blind randomized study from the National Heart, Lung and Blood Institute Women's Ischemia Syndrome Evaluation (WISE)
2011
Adverse Cardiovascular Outcomes in Women With Nonobstructive Coronary Artery Disease
2009
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
Non-invasive detection of apoptosis using magnetic resonance imaging and a targeted contrast agent
2001
Prediction of cardiovascular risk factors from retinal fundus photographs via deep learning
2018 Standout
Angina With “Normal” Coronary Arteries
2005
Mesostructured Silica for Optical Functionality, Nanomachines, and Drug Delivery
2008 StandoutNobel
The use of nanocrystals in biological detection
2003 Standout
First‐pass contrast‐enhanced magnetic resonance angiography in humans using ferumoxytol, a novel ultrasmall superparamagnetic iron oxide (USPIO)‐based blood pool agent
2004
Exercise Standards for Testing and Training
2013 Standout
Magnetic resonance imaging evaluation of myocardial perfusion and viability in congenital and acquired pediatric heart disease
2004
Tissue-specific MR contrast agents
2003
Monomer-Coated Very Small Superparamagnetic Iron Oxide Particles as Contrast Medium for Magnetic Resonance Imaging
2002
Reduced aliasing artifacts using variable-densityk-space sampling trajectories
2000
Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
2009 Standout
Quantitative Retinal Venular Caliber and Risk of Cardiovascular Disease in Older Persons
2006
Cardiovascular magnetic resonance: Structure, function, perfusion, and viability
2005
Cytotoxicity of Nanoparticles
2007 Standout
Superparamagnetic iron oxide nanoparticles (SPIONs): Development, surface modification and applications in chemotherapy
2010 Standout
Single Lipoprotein Apheresis Session Improves Cardiac Microvascular Function in Patients With Elevated Lipoprotein(a): Detection by Stress/Rest Perfusion Magnetic Resonance Imaging
2009
Design and fabrication of magnetic nanoparticles for targeted drug delivery and imaging
2009 Standout
Diagnostic Accuracy of Transesophageal Echocardiography, Helical Computed Tomography, and Magnetic Resonance Imaging for Suspected Thoracic Aortic Dissection
2006
Apical ballooning syndrome (Tako-Tsubo or stress cardiomyopathy): A mimic of acute myocardial infarction
2008 Standout
Standardized image interpretation and post processing in cardiovascular magnetic resonance: Society for Cardiovascular Magnetic Resonance (SCMR) Board of Trustees Task Force on Standardized Post Processing
2013
Magnetic nanoparticles in MR imaging and drug delivery
2008 Standout
Iron oxide MR contrast agents for molecular and cellular imaging
2004 Standout
Superparamagnetic iron oxide contrast agents: physicochemical characteristics and applications in MR imaging
2001
Rheumatoid arthritis
2010 Standout
Recent advances in iron oxide nanocrystal technology for medical imaging☆
2006
Assessment of Ischemic Heart Disease Using Magnetic Resonance First-Pass Perfusion Imaging
2003
Sparse MRI: The application of compressed sensing for rapid MR imaging
2007 Standout
Quantifying Disease Activity and Damage by Imaging in Rheumatoid Arthritis and Osteoarthritis
2009
Women and Ischemic Heart Disease
2009
High Field Magnetic Resonance Imaging Evaluation of Superparamagnetic Iron Oxide Nanoparticles in a Permanent Rat Myocardial Infarction
2003
Effect of Cardiac Rehabilitation on Myocardial Perfusion Reserve in Postinfarction Patients
2008
New generation of monomer-stabilized very small superparamagnetic iron oxide particles (VSOP) as contrast medium for MR angiography: Preclinical results in rats and rabbits
2000
Multimodality Imaging for the Assessment of Severe Aortic Stenosis
2019
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
Clearance Properties of Nano-Sized Particles and Molecules as Imaging Agents: Considerations and Caveats
2008 Standout
2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease
2010 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Pathophysiology and Management of Patients With Chest Pain and Normal Coronary Arteriograms (Cardiac Syndrome X)
2004
Provision of MRI can significantly reduce CT collective dose
2001
Prognosis in Women With Myocardial Ischemia in the Absence of Obstructive Coronary Disease
2004
ACC/AHA 2008 Guidelines for the Management of Adults With Congenital Heart Disease
2008 Standout
Magnetic Iron Oxide Nanoparticles: Synthesis, Stabilization, Vectorization, Physicochemical Characterizations, and Biological Applications
2008 Standout
Multifunctional Inorganic Nanoparticles for Imaging, Targeting, and Drug Delivery
2008 Standout
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Statement for Health Professionals From the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association
2004 Standout
Women’s Ischemic Syndrome Evaluation
2004
ACC/AHA 2008 Guidelines for the Management of Adults With Congenital Heart Disease: Executive Summary
2008 Standout
Comparison of two superparamagnetic viral-sized iron oxide particles ferumoxides and ferumoxtran-10 with a gadolinium chelate in imaging intracranial tumors.
2002
Inorganic nanoparticles in porous coordination polymers
2016 StandoutNobel
Guidelines for Prevention of Stroke in Patients With Ischemic Stroke or Transient Ischemic Attack
2006 Standout
Applications of magnetic nanoparticles in biomedicine
2003 Standout
Endothelial Function
2005
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
2020 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Synthesis, properties, and applications of magnetic iron oxide nanoparticles
2008 Standout
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease
2004 Standout
Magnetic Nanoparticles: Design and Characterization, Toxicity and Biocompatibility, Pharmaceutical and Biomedical Applications
2012 Standout
Remodeling and homeostasis of the extracellular matrix: implications for fibrotic diseases and cancer
2011 Standout
Superparamagnetic iron oxide nanoparticles: from preparations to in vivo MRI applications
2009
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
2014 Standout
2011 ACCF/AHA Focused Update Incorporated Into the ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction
2011
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
Exceedingly small iron oxide nanoparticles as positive MRI contrast agents
2017 StandoutNobel
Estimated Risks of Radiation-Induced Fatal Cancer from Pediatric CT
2001 Standout
Magnetic nanoparticle design for medical diagnosis and therapy
2004 Standout
Fast detection of liver fibrosis with collagen-binding single-nanometer iron oxide nanoparticles via T 1 -weighted MRI
2023 StandoutNobel
Weekend versus Weekday Admission and Mortality from Myocardial Infarction
2007 Standout
Inorganic Nanoparticles for MRI Contrast Agents
2009 Standout
Treatment of Periodontitis and Endothelial Function
2007 Standout
2012 ACCF/AHA Focused Update Incorporated Into the ACCF/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction
2013
Polyethylene glycol-covered ultra-small Gd2O3nanoparticles for positive contrast at 1.5 T magnetic resonance clinical scanning
2007
Works of Jonathan Panting being referenced
Abnormal Subendocardial Perfusion in Cardiac Syndrome X Detected by Cardiovascular Magnetic Resonance Imaging
2002
Feasibility, accuracy and safety of magnetic resonance imaging in acute aortic dissection
1995
Safety and preliminary findings with the intravascular contrast agent NC100150 injection for MR coronary angiography
1999
Echo-planar magnetic resonance myocardial perfusion imaging: Parametric map analysis and comparison with thallium SPECT
2001
Comparison of fast spiral, echo planar, and fast low‐angle shot MRI for cardiac volumetry at .5T
1998
First-pass myocardial perfusion imaging and equilibrium signal changes using the intravascular contrast agent NC100150 injection
1999